VantAI is pioneering a transformative approach to drug discovery by illuminating the dynamic networks of protein interactions that drive biological function. Leveraging our groundbreaking NeoLink structural proteomics platform and next generation foundation models, VantAI generates unprecedented interactomics data at scale, revealing how molecules connect, interact, and shape cellular behavior—in 3D. Alongside a robust and mechanistically differentiated internal pipeline, VantAI collaborates extensively with external partners to accelerate the delivery of innovative therapies. VantAI’s cross-disciplinary team of scientists and engineers is uniquely positioned to unlock novel therapeutic strategies that induce, modulate, or block protein interfaces—making previously undruggable targets accessible and providing powerful new ways to target diseases by rewiring cellular circuitry.
